{"i": ["canagliflozin", "canagliflozin .", "placebo - controlled", "Canagliflozin", "placebo", "CANA", "metformin", "PBO", "orlistat", "lorcaserin", "placebo or canagliflozin", "Placebo"], "o": ["triglycerides and HDL - C levels .", "incidence of serious AEs", "Body weight", "LDL - C / HDL - C ratio", "IWQOL - Lite total scores", "RTG", "candidiasis , vaginal infection , vaginitis bacterial , vulvovaginal mycotic infection , vaginal discharge , and vulvovaginal pruritus", "rates of genital mycotic infections", "body weight", "percent body weight least squares ( LS", "efficacy and safety", "vaginal swabs for Candida culture and urine samples", "hip and waist circumference and waist / hip ratio", "UGE / creatinine ratio and RTG", "hypoglycemia", "impaired fasting glucose", "LDL - C", "overnight UGE", "weight loss nadir", "total scores for IWQOL - Lite", "total caloric losses", "genital mycotic infections", "weight", "24 - h UGE", "mean changes and LS mean differences in waist / hip ratio", "incidences of vulvovaginal mycotic infection , nausea , and sinusitis", "renal glucose reabsorption", "incontinence , micturition urgency , nocturia , pollakiuria , polyuria , stress urinary incontinence", "hypoglycemia episodes", "waist and hip circumference and waist / hip ratio", "body weight reductions", "percent change in body weight", "symptomatic hypoglycemia", "body composition", "Overall adverse event ( AE ) rates", "loss in body weight", "proportion of subjects who lost \u2265 5 % or \u2265 10 % of baseline body weight", "UTIs", "24 - h urinary caloric loss", "osmotic diuresis - related AEs", "UGE", "weight reduction", "urinary caloric loss", "glycemic parameters", "Mean weight loss", "mean body weight", "systolic and diastolic BP", "systolic BP", "pulse rate", "bone resorption", "weight reductions", "urinary glucose excretion", "UGE / creatinine ratio", "elevated FPG", "glycemic parameters , lipids , or BP", "arthralgia and hospitalization due to right hip pain", "total daily UGE", "urinary glucose excretion ( UGE )", "genital mycotic infection ( posthitis", "IWQOL - Lite total score", "intravascular volume", "physical function , self - esteem , sexual life , public distress , and work ),", "bone formation", "Osmotic diuresis - related AE rates", "dizziness )", "UGE .", "waist or hip circumference", "AEs", "anemia secondary to dysfunctional uterine bleeding", "waist circumference and hip circumference", "Urinary tract infection 6", "osmotic diuresis and reduced intravascular volume or symptomatic hypoglycemia", "diastolic BP", "fasting plasma glucose ( FPG ), triglycerides , HDL - C , LDL - C , and LDL - C / HDL - C ratio", "eGFR .", "BUN", "weight - related functioning", "renal threshold for glucose excretion ( RTG )", "medical history , physical examinations , vital sign measurements , clinical laboratory tests , 12 - lead electrocardiograms , and urinalysis .", "overall safety", "blood glucose", "Impact of Weight on Quality of Life - Lite questionnaire ( IWQOL - Lite )", "body weight , BMI , and anthropometric measurements ( LOCF", "normal FPG", "mean percent body weight and absolute body weight", "fasting plasma glucose", "mean BMI", "Weight loss estimates", "plasma glucose or insulin levels", "urge incontinence", "bone specific alkaline phosphatase , osteocalcin", "hemoglobin A1c", "incidence of genital mycotic infections", "body weight .", "mean overnight RTG values", "cholecystitis", "collagen type - 1 \u03b2 - carboxy - telopeptide ( CTX ),", "Adverse events ( AEs", "absolute change in body weight , percent change in body weight , and change in BMI", "serum urate concentrations", "weight loss", "eGFR", "hematocrit and hemoglobin", "serum urate", "blood urea nitrogen ( BUN )", "estimated glomerular filtration rate ( eGFR )", "BMI", "glycemic control", "clinical laboratory parameters", "FPG", "tolerated", "FPG and hemoglobin A1c"]}